Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...